RxDoctor Payments Data

Angela Overcash, PA

Medical · Durham, NCNPI 1376512525

Payments from drug & device makers

$731in general payments, 2019–2025

Across 37 payments — averaging $19.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$347
  • Galderma Laboratories, L.p.$149
  • Lilly USA, LLC$64
  • AbbVie$58
  • Biohaven Pharmaceutical Holding Company Ltd.$51
  • Amgen$28
  • plus $33 from 2 others

What the payments were for

  • Travel & lodging$152%
  • Food & beverage$71598%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$731 in reported general payments places this provider in the 60th percentile of 878 medical providers in North Carolina.

See all medical providers in North Carolina

Medicare billing

Part B allowed, 2024
$40,185
Medicare patients
95
Services billed
447

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide49$66,949
OzempicSemaglutide27$52,359
Janumet XrSitagliptin Phos/Metformin Hcl11$11,193
Emgality PenGalcanezumab-Gnlm12$8,337
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog11$7,783
Novolog FlexpenInsulin Aspart14$5,256
Lantus SolostarInsulin Glargine,hum.Rec.Anlog14$2,771
Amlodipine-OlmesartanAmlodipine Bes/Olmesartan Med24$2,119
Olmesartan-Amlodipine-HctzOlmesartan/Amlodipin/Hcthiazid15$1,987
SynthroidLevothyroxine Sodium17$1,970
Olmesartan Medoxomil95$1,553
Rosuvastatin Calcium120$1,267
Levothyroxine Sodium73$947
Fluoxetine Hcl52$932
Atorvastatin Calcium84$825

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$64$66,94949 claims
Novo NordiskOzempic$347$52,35927 claims
AbbVieSynthroid$58$1,97017 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 878 medical providers in North Carolina.

Other medical in Durham

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →